Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    SPINK2 Antibody, mFluor Violet 610 SE, Novus Biologicals™
 
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP282015MFV610
Description
SPINK2 Polyclonal antibody specifically detects SPINK2 in Human, Mouse samples. It is validated for Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry (Paraffin)Specifications
| SPINK2 | |
| Polyclonal | |
| Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin | |
| Acrosin-trypsin inhibitor, Kazal type 2 (acrosin-trypsin inhibitor), serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor), serine protease inhibitor Kazal-type 2, serine protease inhibitor, Kazal type, 2 (acrosin-trypsin inhibitor) | |
| SPINK2 antibody was raised against a 16 amino acid synthetic peptide near the carboxy terminus of mouse SPINK2. The immunogen is located within the last 50 amino acids of SPINK2. Amino Acid Squence: KIREDGSHINIIKDE | |
| 0.1 mL | |
| Primary | |
| Human, Mouse | |
| Purified | 
| Western Blot, ELISA, Immunohistochemistry, Immunocytochemistry, Immunohistochemistry (Paraffin) | |
| mFluor Violet 610 SE | |
| 50mM Sodium Borate | |
| Rabbit | |
| Peptide affinity purified | |
| RUO | |
| 6691 | |
| Store at 4C in the dark. | |
| IgG | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction
            